CC
AGN

Clearline Capital’s Allergan plc AGN Stock Holding History

Clearline Capital’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-25,335
Closed -$4.22M – 61
2018
Q2 		$4.22M Buy
25,335
+21,899
+637% +$3.52M 2.75% 14
2018
Q1 		$578K Buy
+3,436
New +$576K 0.53% 34
2017
Q1 		– Sell
-63,699
Closed -$13.4M – 70
2016
Q4 		$13.4M Sell
63,699
-144,512
-69% -$29.9M 6.07% 4
2016
Q3 		$48M Buy
+208,211
New +$50.9M 14.96% 1
2014
Q2 		– Sell
-73,183
Closed -$15.1M – 66
2014
Q1 		$15.1M Buy
+73,183
New +$14.5M 3.42% 10

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Clearline Capital's AGN Position: Q3 2018 in Review

Clearline Capital sold out of Allergan plc (AGN) in Q3 2018, closing a stake of 25,335 shares — an estimated $4.22M sold.

Clearline Capital first reported a position in AGN in Q1 2014 and held it in 5 quarters. The position peaked at $48M in Q3 2016. 1,066 funds tracked by Wall St. Rank hold AGN as of Q3 2018.

  • Clearline Capital reported no remaining Allergan plc position as of Q3 2018 after selling out during the quarter.
  • Clearline Capital sold 25,335 Allergan plc shares in Q3 2018, an estimated $4.22M.
  • Clearline Capital first reported a position in Allergan plc in Q1 2014 and held it in 5 quarters.
  • Clearline Capital's Allergan plc position peaked at $48M in Q3 2016.
  • 1,066 funds tracked by Wall St. Rank held Allergan plc as of Q3 2018.

Based on Clearline Capital's 13F filing for Q3 2018, filed 14 Nov 2018.